1 The release of acetylcholine was investigated in the human placenta villus, a useful model for the characterization of the non-neuronal cholinergic system. 2 Quinine, an inhibitor of organic cation transporters (OCT), reduced acetylcholine release in a reversible and concentration-dependent manner with an IC 50 value of 5 mM. The maximal e ect, inhibition by 99%, occurred at a concentration of 300 mM. 3 Procaine (100 mM), a sodium channel blocker, and vesamicol (10 mM), an inhibitor of the vesicular acetylcholine transporter, were ine ective. 4 Corticosterone, an inhibitor of OCT subtype 1, 2 and 3 reduced acetylcholine in a concentrationdependent manner with an IC 50 value of 2 mM. 5 Substrates of OCT subtype 1, 2 and 3 (amiloride, cimetidine, guanidine, noradrenaline, verapamil) inhibited acetylcholine release, whereas carnitine, a substrate of subtype OCTN2, exerted no e ect. 6 Long term exposure (48 and 72 h) of villus strips to anti-sense oligonucleotides (5 mM) directed against transcription of OCT1 and OCT3 reduced the release of acetylcholine, whereas OCT2 antisense oliogonucleotides were ine ective. 7 It is concluded that the release of non-neuronal acetylcholine from the human placenta is mediated via organic cation transporters of the OCT1 and OCT3 subtype. IntroductionAcetycholine has been demonstrated in the vast majority of human non-neuronal cells, for example epithelial, endothelial, mesothelial and immune cells as well as smooth muscle ®bres (Grando, 1997;Wessler et al., 1998;Kawashima & Fujii, 2000). In addition, nicotinic and muscarinic receptors are widely expressed on these cells (Brunner & Kukovetz, 1986;Grando et al., 1995;Maus et al., 1998;Costa et al., 1988;Kawashima & Fujii, 2000). Non-neuronal acetylcholine can act as a local cell molecule via paracrine and autocrine mechanisms to control basic cell functions such as proliferation, di erentiation and cell ± cell contact (Grando, 1997;Wessler et al., 1998;Kawashima & Fujii, 2000). The release mechanisms by which non-neuronal cells, for example epithelial cells of the placenta, liberate acetylcholine into the extracellular space, are unknown. The human placenta is not innervated by extrinsic or intrinsic cholinergic neurons (Sastry & Sadavongvivad, 1979;Sastry, 1997). Thus, released acetylcholine is not contaminated by neuronal acetylcholine and can be used as a model for studying the release mechanisms of non-neuronal acetylcholine. Acetylcholine, an organic cation, may be a substrate for organic cation transporters (OCT). OCTs are most widely expressed in di erent cell types including the human placenta (Koepsell, 1998;Dresser et al., 1999). Three organic cation transporters have been cloned which represent high capacity non-neuronal monoamine transporters, OCT subtype 1 (GruÈ ndemann et al., 1994;Nagel et al., 1997), subtype 2 (Okuda et al., 1996 GruÈ ndemann et al., 1997; and subtype 3, the latter also being known as extraneuronal monoamine transporter uptake 2 (GruÈ ndemann et al., 1998;Kekuda et al., 1998;Wu et al., 1998). To ...
The objective of this study was to assess whether the presence of human papillomavirus (HPV) DNA and/or several genotypes of HPV DNA in cervical cancer are correlated with several clinicopathologic parameters of well-defined prognostic significance and whether virologic parameters are predictors of long-term survival in cancer patients. Two hundred twenty three cases of cervical cancer patients included in this retrospective study underwent follow-up evaluation. Survival and cause of death were examined for 204 (91.4%) patients, with a mean follow-up time of 4.4 years. HPV DNA was detected using the highly sensitive polymerase chain reaction (PCR) method followed by HPV DNA sequencing for HPV genotyping. These results were correlated with well-defined clinicopathologic parameters and survival data. HPV DNA was detected by PCR in 150 of 193 (73.4%) tissue specimens of cervical cancer patients. DNA sequence analysis revealed the presence of HPV 16 (n = 68, 45.3%), HPV 18 (n = 49, 32.6%) and rare HPV types (n = 33, 22.1%). HPV genotypes correlated significantly with histologic tumor types, node status, tumor oxygenation, blood vessel invasion, and lymph space involvement. The presence of HPV DNA in cervical cancer as well as the genotype of HPV 16 could also be confirmed as significant prognostic factors in the univariate Cox regression analysis (RR 2.856, P < 0.003 resp. RR 3.444, P < 0.0001). In the multivariate analysis, however, HPV DNA status failed to be of prognostic relevance. Exclusively HPV 16 appears to have an independent impact on the overall survival in cervical patients (RR 3.653, P < 0.002). We conclude that the detection of HPV 16 genotype may play an important adjunct role in assessing prognosis of cervical cancer patients. The clinical impact of the presence of HPV DNA in primary tumors of uterine cervix remains to be investigated in further studies, and the exact mechanisms by which HPV influences the prognosis of cervical cancer patients have to be defined.
The detection of HPV 16 genotype may play an important adjunct role in assessing prognosis of cervical cancer patients. The clinical impact of the presence of HPV DNA in primary tumors and cancer free pelvic lymph nodes remains to be investigated in further studies. The exact mechanisms by which HPV influence the prognosis of cervical cancer patients have to be defined.
It is generally accepted that local growth of solid tumors and their ability to establish distant metastases are dependent on the formation of new blood vessels arising from preexisting ones (angiogenesis). The angiogenic response of the host is mediated by angiogenic molecules that are released from cancer and normal stroma cells, especially fibroblasts. The goal of the present study was to quantitatively compare the expression of the two most important angiogenic growth factors (VEGF, angiogenin) of cervical cancer cells (HeLa and Me-180) with that of cervical cancer-derived fibroblasts (from one tumor/patient) under defined normoxic and hypoxic conditions in vitro. The growth kinetics of cervical cancer cells (HeLa and Me-180) and tumor-derived fibroblasts were evaluated in vitro under normoxic and hypoxic conditions. Growth factor concentrations in the cell culture medium were measured by ELISA and the secretion rates per cell were calculated. Under normoxic conditions, both the cervical cancer cells as well as the tumor-derived fibroblasts released VEGF and angiogenin. The secretion rate of both angiogenic factors was significantly higher in the stroma cells than in the tumor cells (P < 0.05). VEGF and angiogenin secretion is significantly higher in the stroma cells under hypoxia than in the tumor cells investigated (P < 0.05). The presented data support the concept that in cervical cancer non-neoplastic fibroblasts could play a pivotal role in the complex process of tumor angiogenesis.
It is generally accepted that local growth of solid tumors and their ability to establish distant metastases are dependent on the formation of new blood vessels arising from preexisting ones (angiogenesis). The angiogenic response of the host is mediated by angiogenic molecules that are released from cancer and normal stroma cells, especially fibroblasts. The goal of the present study was to quantitatively compare the expression of the two most important angiogenic growth factors (VEGF, angiogenin) of cervical cancer cells (HeLa and Me-180) with that of cervical cancer-derived fibroblasts (from one tumor/patient) under defined normoxic and hypoxic conditions in vitro. The growth kinetics of cervical cancer cells (HeLa and Me-180) and tumor-derived fibroblasts were evaluated in vitro under normoxic and hypoxic conditions. Growth factor concentrations in the cell culture medium were measured by ELISA and the secretion rates per cell were calculated. Under normoxic conditions, both the cervical cancer cells as well as the tumor-derived fibroblasts released VEGF and angiogenin. The secretion rate of both angiogenic factors was significantly higher in the stroma cells than in the tumor cells (P < 0.05). VEGF and angiogenin secretion is significantly higher in the stroma cells under hypoxia than in the tumor cells investigated (P < 0.05). The presented data support the concept that in cervical cancer non-neoplastic fibroblasts could play a pivotal role in the complex process of tumor angiogenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.